Status:
UNKNOWN
Hyperalgesia in Methadone Patients: Can it be Treated?
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-induced Hyperalgesia
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
In the proposed study, we will build upon our previous studies validating and characterizing hyperalgesia in MM samples to explore it's underlying mechanism from a pharmacological perspective. Utilizi...
Detailed Description
Addressing the undertreatment of clinical pain has become a national priority, with a central goal being to identify effective interventions for those subgroups of patients most at risk for suffering ...
Eligibility Criteria
Inclusion
- Inclusion criteria: Potential participants must:
- Be between the ages of 18 and 55 years of age.
- Fulfill DSM-IV criteria for opiate dependence.
- Be compliant in MM treatment and on a stable dose of methadone x 6 weeks.
- Be in good physical health or in the case of a medical condition needing ongoing treatment, be in the care of a physician who is willing to take responsibility for such treatment. The same conditions apply in cases of patients with a psychiatric disorder needing ongoing treatment.
- Be agreeable to and capable of signing an informed consent.
Exclusion
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00333242
Start Date
September 1 2002
Last Update
January 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA School of Nursing
Los Angeles, California, United States, 90095